XPhyto entering the $60 billion per year worldwide PCR testing market in April with a best in class PCR kit and a strong commercial team behind them. And their their diagnostics segment wont even be their strongest revenue generator. Their drug delivery platforms have enormous potential. I dont think it will be long before we see partnerships with big pharma or see XPhyto acquired for a healthy
...more